FDA 483 - The Procter & Gamble Manufacturing Company - March 10, 2017

During an inspection of Procter & Gamble Manufacturing Co in Browns Summit, NC, the FDA observed issues with laboratory recordkeeping. Specifically, a second person verifier signed off on testing logbooks without adequately authenticating the accuracy of the results or recorded information. This indicates a lapse in quality control procedures for laboratory data.